Ligand Pharmaceuticals Inc (LGND)
EBITDA Growth
696.51%
TTM · Period ending:
LGND EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported696.51%period ending
Latest reported696.51%period ending
LGND TTM EBITDA YoY % (40.22% → 696.51%)
Year-over-year change
High-resolution chart · PNG
LGND ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 10.3975% | |
| 9.8158% | |
| 13.4219% | |
| 24.4774% | |
| 28.6164% | |
| 23.4498% | |
| 20.9451% | |
| -40.8481% | |
| -85.4037% | |
| -143.7751% | |
| -196.1722% | |
| -32.5503% | |
| -31.9672% | |
| 0.4% | |
| 9.9138% | |
| -39.9061% | |
| 5.0584% | |
| -98.4127% | |
| -110.9091% | |
| -159.7561% | |
| -343.1034% | |
| 24.0964% | |
| 40.2174% |